Status:
COMPLETED
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
Lead Sponsor:
Alberta Health services
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
PHASE1
PHASE2
Brief Summary
Many patients with localized prostate cancer choose radiotherapy for treatment. Recent improvements in technology have lead to better outcomes with less side effects and better disease control rates b...
Detailed Description
Purpose: * To determine the acute and late effects of high-dose short-course hypofractionated radiotherapy of 55 Gy/16 fraction/4 weeks in the treatment of localized prostate cancer. * To provide cli...
Eligibility Criteria
Inclusion
- Low/intermediate risk localized prostate cancer
Exclusion
- High risk, metastatic
- Patient refusal
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00129025
Start Date
October 1 2004
End Date
December 1 2006
Last Update
October 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2